about
From the stomach to other organs: Helicobacter pylori and the liverSerum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosisSerum adipokines in inflammatory bowel disease.Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis CChanges in subcellular localization of visfatin in human colorectal HCT-116 carcinoma cell line after cytochalasin B treatment.Effects of ghrelin, leptin and melatonin on the levels of reactive oxygen species, antioxidant enzyme activity and viability of the HCT 116 human colorectal carcinoma cell line.Angiogenesis: a phenomenon which aggravates chronic liver disease progression.Omentin serum concentration and hepatic expression in chronic hepatitis C patients - together or apart?Long-term Effect of Ileal Transposition on Adipokine Serum Level in Zucker (Orl)-Lepr(fa) Fatty Rats.Hepatic angiogenesis and fibrosis are common features in morbidly obese patients.Digestive enzymes activity in subsequent generations of Cameraria ohridella larvae harvested from horse chestnut trees after treatment with imidacloprid.Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease.Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease.Serum Levels of Visfatin, Omentin and Irisin in Patients with End-Stage Lung Disease Before and After Lung Transplantation.Ileal Transposition (IT) Surgery Changing the Ultrastructure of the Transposed Segment as well as Jejunum. Histomorphometric and Electron Microscopy Analysis.Serum vaspin concentrations in girls with anorexia nervosa.Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study.Pharmacological and dietary factors in prevention of colorectal cancerCirculating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate CancerThe role of metabolic disorders in the pathogenesis of intrahepatic cholestasis of pregnancyThe influence of high-fat, high-sugar diet and bariatric surgery on HSP70 and HSP90 plasma and liver concentrations in diet-induced obese ratsSmall intestinal bacterial overgrowth and nonalcoholic fatty liver diseaseInsulin resistance and its consequences in chronic hepatitis CHepatocyte growth factor and epidermal growth factor activity during later stages of rat liver regeneration upon interferon α-2b influenceUnderrated enemy - from nonalcoholic fatty liver disease to cancers of the gastrointestinal tractDiabetes-Related Knowledge of Polish National Mountain LeadersNatural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized ApproachMucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia (GAVE)Serum Adipokine Levels in Patients Considered for Lung TransplantationEvaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver diseaseSteatosis influences hepatocytes proliferative potential in chronic hepatitis C patientsSerum visfatin and vaspin levels in hepatocellular carcinoma (HCC)The influence of high fat diet on plasma incretins and insulin concentrations in Sprague-Dawley rats with diet-induced obesity and glucose intolerance undergoing ileal transpositionCOVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature
P50
Q26795532-CB205314-ADEF-4C12-AB67-24DFA0C71F5FQ33572695-0B8CB798-DB17-4478-BFA3-EB6222C95EB0Q33735303-E6EA2198-13C2-412C-8AA0-19E6E50A29CEQ33993946-7D79CD54-B2EE-41D2-9424-5C82E7C2EA2BQ34325856-8EA118AA-1CA8-4848-B1DF-3B8911222621Q38887296-9C766A22-FC4D-4581-8460-5C3FB7677857Q40707714-31975D6C-805B-496F-88A2-B03B3C4165A4Q40890008-CB698C80-23FB-46D9-B85C-A21BFE7C7172Q41389447-D404AA63-E88F-4447-BBE5-F835F5533DC6Q41872219-CB0579D7-F41A-4A19-8769-73C661334A98Q42005931-A5E07B7B-B48A-43D2-B937-965F6AB90F16Q47661075-F7A05029-8C6A-4818-BCA0-D69E0712D74FQ47661087-47084EE2-C3B5-464D-AE7B-11AF1D449B4DQ47670217-F1E454A7-E6CE-4A34-9A39-A83CA5D2EECEQ48365768-5B678741-0CEE-4F20-8CE9-0AB8A34BEE43Q53790811-A7A165FA-87AA-4797-AC1A-1B733E2F005CQ55339550-C1E1847F-C1A7-4B56-832B-4B131E8E06BFQ57118426-E4082EAE-D925-44BD-B474-C69A436A63BCQ58773054-E23389AF-A8C9-464A-BF5E-AFEC85E6298EQ60920542-7D63C089-E040-4944-813F-44F8B7505A3CQ64055990-0B8CAB19-6A91-44E8-BB4D-29E0E4910F0AQ64276819-9DB8CDBC-E7A5-42C8-97F2-27B62E2F00FFQ88881039-7569DFDD-66FE-4538-9E0B-25BF08B95814Q88881173-BBD8E37F-7D38-4E15-8461-D6B1D83B4CBDQ89110155-1F204C7A-FF5B-4E9A-A8A6-AA90E19618A5Q89166802-A233E115-5DF8-4C2A-A56E-0A30EFB84B2DQ89687819-87D3F373-EB0E-42C5-AE20-EA1E9AE72E60Q90946613-58124273-5311-442F-A61E-662077E761FBQ91274436-6C4D8AAC-6AFF-4D20-8780-FBF9BDF6C3D2Q91705561-DF14600F-60C0-4C22-9380-5D9A0E49B017Q91754078-57F6FF32-B609-4709-82B6-31C52CC6D363Q92626563-A6079A74-CFC4-4F49-98BD-B544413F664CQ92895718-32F164ED-3A85-454E-81C6-BBD573F14CBBQ94664973-5B0BA236-251B-4651-B80A-8F731E960101
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Michał Kukla
@en
Michał Kukla
@nl
type
label
Michał Kukla
@en
Michał Kukla
@nl
prefLabel
Michał Kukla
@en
Michał Kukla
@nl
P31
P496
0000-0002-7900-1094